Lux Ventures V, L.P.
SEC CIK 1698008 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EIKN | Eikon Therapeutics, Inc. | 10% | 2.39M | $5.00M | — | 2 | 2026-02-04 | 2026-02-06 |
Most active insiders at EIKN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Column Group Opportunity III, LP | 10% | $38.12M | — |
| 2 | Wolfe Josh | Dir, 10% | $5.00M | — |
| 3 | Lux Ventures V, L.P. | 10% | $5.00M | — |
| 4 | FRAZIER KENNETH C | Dir | $2.00M | — |
| 5 | Column Group IV GP, LP | 10% | $1.03M | — |
| 6 | Foresite Capital Opportunity Management V, LLC | 10% | $1000.0K | — |
| 7 | PERLMUTTER ROGER M | See remarks, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-02-06 | 2026-02-04 | EIKN | Eikon Therapeutics, Inc. | Lux Ventures V, L.P. | 10% | P - Purchase | $18.00 | +277.8K | 138.9K | New | +$5.00M |
| DMI | 2026-02-06 | 2026-02-06 | EIKN | Eikon Therapeutics, Inc. | Lux Ventures V, L.P. | 10% | C - Cnv Deriv | — | +5.70M | 2.39M | New | — |
Purchase Sale Sale after option exercise All abbreviations